Prostatic Neoplasms: all 6,484 studies
Page 9 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- Observational Study of Patients Who Underwent Diagnostic Investigation (Prostate Biopsy) and/or Radical Prostatectomy Surgery.RecruitingNCT06397755
- ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate CancerRecruitingNCT06397703Phase 2
- A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid MalignanciesRecruitingNCT06395519Phase 1/2
- Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer DiagnosisRecruitingNCT06392737Not applicable
- PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate CancerRecruitingNCT06392295Phase 2
- Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate CancerRecruitingNCT06391034Phase 2
- Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate CancerRecruitingNCT06389786Not applicable
- SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment OptimizationRecruitingNCT06389097
- Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)RecruitingNCT06387056Phase 2
- To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate CancerRecruitingNCT06385847Phase 2
- Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE TrialRecruitingNCT06378866Phase 2
- GU-01: Glycyrrhizin in Prostate CancerRecruitingNCT06378346Phase 2
- Decade-Long Insights Into Transperineal Prostate Biopsy in a West China PopulationNot yet recruitingNCT06366308
- AI-based Measurements of Tumour Burden in PSMA PET-CTRecruitingNCT06363435
- A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their CaregiversRecruitingNCT06363266Not applicable
- Clinical Study of HIFU for Localized Prostate CancerRecruitingNCT06362577
- To Evaluate an MRI-based Optimized Prostate Cancer Diagnostic Pathway Powered by Artificial IntelligenceRecruitingNCT06360523Not applicable
- The Man Van ProjectRecruitingNCT06357416Not applicable
- Real World Prostate Cancer RegistryRecruitingNCT06355336
- New Urethral Reconstruction in Robot-assisted Laparoscopic Radical ResectionRecruitingNCT06355076Not applicable
- Ultrahypofractionated, Adaptive Radiation Therapy of Prostate CancerRecruitingNCT06355050
- Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1RecruitingNCT06353321
- Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC PatientsRecruitingNCT06350825Phase 3
- A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate CancerRecruitingNCT06347705Phase 2
- Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active SurveillanceRecruitingNCT06343077Phase 2
- Targeted Radionuclide Therapy in Metastatic Prostate Cancer Using a New PSMA Ligand Radiolabelled With Terbium-161 (161Tb-SibuDAB) - Dose Identification/Escalation Phase Ia/b StudyRecruitingNCT06343038Phase 1
- Adjuvant Hypofractionated Radiotherapy for Prostate CancerRecruitingNCT06335693Not applicable
- INSIDE: Identification of Genomic Screening Pathways in Cancer Patients With DNA Repair AlterationsRecruitingNCT06334809
- CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancErRecruitingNCT06331013Not applicable
- Image-guided Focal Dose Escalation- Primary pc Treated With Primary External Beam Hypofract.Stereotactic rtRecruitingNCT06330909Not applicable
- Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate CancerRecruitingNCT06330805Phase 2
- Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate CancerRecruitingNCT06325995Not applicable
- Radical Hypofractionated Radiotherapy for Localized Prostate CancerRecruitingNCT06325774Not applicable
- Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate CancerRecruitingNCT06325046Not applicable
- Response Evaluation of Cancer Therapeutics in Metastatic Castration-Resistant Prostate Cancer to the BoneRecruitingNCT06321679
- PROMISE PET Registry on PSMA-PET and Outcome in Prostate CancerRecruitingNCT06320223
- Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D InterventionRecruitingNCT06318559Not applicable
- Improving the Quality of Radiotherapy by Multi-Institution Knowledge-Based Planning Optimization Models (Acronym: MIKAPOCo, Multi-Institutional Knowledge-based Approach in Plan Optimization for the Community)Enrolling by invitationNCT06317948
- Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRIRecruitingNCT06315595
- Comparison of Spinal Anesthesia and Spermatic Cord Block for Bilateral OrchiectomyEnrolling by invitationNCT06313775Not applicable
- CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate CancerRecruitingNCT06306612Not applicable
- Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate CancerRecruitingNCT06305832Phase 2
- Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of csPCa: the PROFUSION TrialRecruitingNCT06303622Not applicable
- MRI Guided Prostate BiopsyRecruitingNCT06302595Not applicable
- High-resolution Intra-operative PSMA PET-CT in Prostate CancerNot yet recruitingNCT06298838
- Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer ProgressionRecruitingNCT06292897
- Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA TrialRecruitingNCT06288113Phase 2
- Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular TracersRecruitingNCT06282588Phase 2/3
- Imperial Prostate 9 - ATLAS (Approaches To Long-Term Active Surveillance)RecruitingNCT06280781Not applicable
- National Robotics-Assisted Radical Prostatectomy DatabaseRecruitingNCT06279260
- Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional ImagingRecruitingNCT06276465Phase 3
- Remote Monitoring of Patient Reported Outcomes to Improve the Efficacy of the Acute Phase Radiotherapy Review ProcessRecruitingNCT06274892Not applicable
- Feasibility of Virtual Reality Assistance in Prostate Biopsy Under Local Anesthesia.Not yet recruitingNCT06274684Not applicable
- PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.RecruitingNCT06274047Phase 3
- OLIGOS: Impact of Treatment on Primary Tumour in Patients With Newly Diagnosed Oligometastatic Neoplasia of the ProstateRecruitingNCT06273345
- Transdermal Estradiol and Exercise in Mitigating Adverse Effects of Androgen Deprivation Therapy for Prostate Cancer Radiation TherapyNot yet recruitingNCT06271551Phase 2
- Focal Therapy for Localized Prostate CancerRecruitingNCT06270043
- Study of AZD0754 in Participants With Metastatic Prostate CancerRecruitingNCT06267729Phase 1/2
- A Multi-centre Trial on Targeted Microwave Ablation (TMA) for Localized Prostate CancerRecruitingNCT06262633Not applicable
- Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer PatientsRecruitingNCT06262139Phase 1/2
- Data Collection in Lutetium Treated Prostate Cancer: Recording of Progression and Tumor CharacteristicsRecruitingNCT06260410
- High Impact Training to Patients with Prostate Cancer and Bone MetastasesRecruitingNCT06259279Not applicable
- Neoadjuvant PSMA-RLT in Oligometastatic PCaRecruitingNCT06259123Phase 2
- Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID)RecruitingNCT06251492Phase 2
- 177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate CancerRecruitingNCT06250244Phase 1/2
- Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate CancerRecruitingNCT06249750Phase 2
- FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY TrialRecruitingNCT06244004Phase 2
- Clinical Application of the J-PET Scanner PrototypeRecruitingNCT06242119
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsRecruitingNCT06239194Phase 1/2
- Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP)RecruitingNCT06238713Not applicable
- Prostate Cancer Screening: a Pilot StudyEnrolling by invitationNCT06238661Not applicable
- The Safety and Dosimetry Study of 177Lu-LNC1003 InjectionNot yet recruitingNCT06237491Phase 1
- Behavioral Exercise Training to Reduce Cardiovascular Disease RiskRecruitingNCT06237179Phase 1/2
- Observation Study to Evaluate the Efficacy and Safety of Ifosfamide/Mesna in Patients With Metastatic Castration-resistant Prostate CancerRecruitingNCT06236789
- Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate CancerRecruitingNCT06236139Phase 1/2
- Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate TreatmentRecruitingNCT06235697Phase 3
- Disitamab Vedotin in the Treatment With HER2- Expression, Subjects With Locally Advanced or Metastatic Castration-resistant Prostate CancerRecruitingNCT06227156Phase 2
- Effectiveness of Focal Therapy in Men With Prostate CancerRecruitingNCT06223295Not applicable
- Nurse-led Proactive Telephone Follow-up With Patients After Completion of Primary Cancer TreatmentEnrolling by invitationNCT06223022Not applicable
- Tumor-directed Radiation Therapy for Patients With the Highest Risk Category of Localized Prostate CancerRecruitingNCT06220435Not applicable
- PSMA-RLT in Biochemically Recurrent PCaRecruitingNCT06220188Phase 2
- 99mTc-MIP-1404 SPECT/CT in Primary Staging of Prostate CancerRecruitingNCT06219746Not applicable
- Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)RecruitingNCT06216249Phase 2
- Geriatric Assessment and Technology Evaluation in Prostate CancerRecruitingNCT06215508
- Correlation Between PSA Levels and F-18 PSMA PET/CT Findings in Prostate Cancer PatientRecruitingNCT06209853
- Towards Optimal Treatment for High Risk Prostate CancerRecruitingNCT06204341Not applicable
- CV CARE: CardioVascular Care in PC PatientsRecruitingNCT06202820Not applicable
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Non-Metastatic Locally Recurrent Prostate Cancer.RecruitingNCT06202248Not applicable
- A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled ZT-111 in Patients With Metastatic Prostate CancerRecruitingNCT06201741Not applicable
- Stereotactic Re-irradiation of Local Recurrences of Prostate Cancer After RadiotherapyRecruitingNCT06201078Phase 2
- Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate CancerRecruitingNCT06200974
- ARON-3 Study: International Multicentric Retrospective Study to Collect Global Experiences in the Treatment of Patients With Metastatic PCaRecruitingNCT06200558
- Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot PlacementRecruitingNCT06200259Not applicable
- Radiotherapy for Prostate and Oligo-metastatic Lesions in Patients With Low-burden Oligo-metastatic Prostate CancerNot yet recruitingNCT06198387Not applicable
- LTFU for All Cell and Gene Therapy StudiesNot yet recruitingNCT06194461
- Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate CancerRecruitingNCT06190899Phase 1/2
- Prostatic Size Reduction Following of Leuprorelin AcetateRecruitingNCT06184464
- Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate CancerRecruitingNCT06178354Not applicable
- Pilot Study of Dose Escalation in Prostate Radiotherapy Using the MR-Linac (DESTINATION-MRL)RecruitingNCT06177093Not applicable
- Intermittent Darolutamide Treatment in the Triple Therapy of mHSPCRecruitingNCT06177015Phase 3